Literature DB >> 23594950

Molecular mechanisms underlying RB protein function.

Frederick A Dick1, Seth M Rubin.   

Abstract

Inactivation of the RB protein is one of the most fundamental events in cancer. Coming to a molecular understanding of its function in normal cells and how it impedes cancer development has been challenging. Historically, the ability of RB to regulate the cell cycle placed it in a central role in proliferative control, and research focused on RB regulation of the E2F family of transcription factors. Remarkably, several recent studies have found additional tumour-suppressor functions of RB, including alternative roles in the cell cycle, maintenance of genome stability and apoptosis. These advances and new structural studies are combining to define the multifunctionality of RB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23594950      PMCID: PMC4754300          DOI: 10.1038/nrm3567

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  91 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes.

Authors:  Michael Korenjak; Barbie Taylor-Harding; Ulrich K Binné; John S Satterlee; Olivier Stevaux; Rein Aasland; Helen White-Cooper; Nick Dyson; Alexander Brehm
Journal:  Cell       Date:  2004-10-15       Impact factor: 41.582

3.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

Review 4.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

5.  A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.

Authors:  W Pan; S Cox; R H Hoess; R H Grafström
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

6.  Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.

Authors:  Ulrich K Binné; Marie K Classon; Frederick A Dick; Wenyi Wei; Michael Rape; William G Kaelin; Anders M Näär; Nicholas J Dyson
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

7.  The retinoblastoma protein regulates pericentric heterochromatin.

Authors:  Christian E Isaac; Sarah M Francis; Alison L Martens; Lisa M Julian; Laurie A Seifried; Natalie Erdmann; Ulrich K Binné; Lea Harrington; Piotr Sicinski; Nathalie G Bérubé; Nicholas J Dyson; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 8.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

9.  Shared role of the pRB-related p130 and p107 proteins in limb development.

Authors:  D Cobrinik; M H Lee; G Hannon; G Mulligan; R T Bronson; N Dyson; E Harlow; D Beach; R A Weinberg; T Jacks
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

10.  Targeted disruption of p107: functional overlap between p107 and Rb.

Authors:  M H Lee; B O Williams; G Mulligan; S Mukai; R T Bronson; N Dyson; E Harlow; T Jacks
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

View more
  230 in total

1.  Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Yi Liu; Christopher McNair; Alex Haber; Maryna Perepelyuk; Anshul Bhardwaj; Sankar Addya; Adam Ertel; Sunday Shoyele; Ruth Birbe; Joseph M Salvino; Adam P Dicker; Karen E Knudsen; Robert B Den
Journal:  Clin Cancer Res       Date:  2018-01-08       Impact factor: 12.531

Review 2.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

3.  The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency.

Authors:  Satyaki Sengupta; Raj Lingnurkar; Timothy S Carey; Monica Pomaville; Parimal Kar; Michael Feig; Catherine A Wilson; Jason G Knott; David N Arnosti; R William Henry
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

4.  An RB insensitive to CDK regulation.

Authors:  Manel Joaquin; Eulàlia de Nadal; Francesc Posas
Journal:  Mol Cell Oncol       Date:  2016-12-14

5.  Structural and functional characterization of the acidic region from the RIZ tumor suppressor.

Authors:  Yizhi Sun; Jessica M Stine; Daniel Z Atwater; Ayesha Sharmin; J B Alexander Ross; Klára Briknarová
Journal:  Biochemistry       Date:  2015-02-02       Impact factor: 3.162

Review 6.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

Review 7.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

8.  Role of Drosophila retinoblastoma protein instability element in cell growth and proliferation.

Authors:  Jared S Elenbaas; Rima Mouawad; R William Henry; David N Arnosti; Sandhya Payankaulam
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.

Authors:  Tyler J Liban; Michael J Thwaites; Frederick A Dick; Seth M Rubin
Journal:  J Mol Biol       Date:  2016-08-25       Impact factor: 5.469

Review 10.  The dynamic control of signal transduction networks in cancer cells.

Authors:  Walter Kolch; Melinda Halasz; Marina Granovskaya; Boris N Kholodenko
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.